Categories
Anti Cancer Breakthrough Therapies cancer research Coco the Koala Reports Courage Foundation Projects drug repurposing Drug Repurposing & Innovation Integrative Oncology Insights integrative-oncology Ivermectin MD Anderson Mebendazole Natural Treatments Non-Chemo Cancer Treatments Repurposed Drug Studies Research & Science Research News & Updates

Coco’s Big News: Courage Against Cancer Joins Forces with MD Anderson!

G’day mates — it’s me, Coco the Koala, and I can hardly contain my excitement! Today’s a historic moment for our Courage Against Cancer family. 🧬

We’ve just submitted our very first Sponsored Research Agreement (SRA) to MD Anderson Cancer Center — one of the world’s leading institutions in cancer research. Together, we’re launching a preclinical trial studying ivermectin and mebendazole as potential treatments against ovarian cancer.

It’s the first courageous step toward FDA-approved, non-chemotherapy cancer therapies — and I’m beaming with hope! Stay tuned as we climb this new branch of discovery, one brave leaf at a time.

Stay Courageous, mates. Healing is possible.
— Coco the Koala 🐨

Coco the Koal is excited to be holding a Sponsored Research Agreement

Hi everyone, Sean here from Courage Against Cancer. I’m beyond proud to share an incredible milestone — our foundation has just submitted and anticipate signing its first Sponsored Research Agreement with MD Anderson Cancer Center soon!

This marks the official launch of a preclinical study on ivermectin and mebendazole in ovarian cancer, the beginning of our mission to bring forward the first non-chemo, non-radiation-based therapy for FDA review.

In this video, I’ll explain what this collaboration means for patients, researchers, and the future of integrative oncology — and how your support makes all of this possible.

Discover more from Courage Against Cancer

Subscribe to get the latest posts sent to your email.

One reply on “Coco’s Big News: Courage Against Cancer Joins Forces with MD Anderson!”

Leave a reply to Combining Ivermectin & Mebendazole with Standard Cancer Therapies: Exploring Potential Synergies in the Fight Against Cancer – Courage Against Cancer Cancel reply